These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6306746)

  • 1. Cerebellar cyclic GMP in p,p'-DDT myoclonus: effects of antimyoclonic agents.
    Chung E
    Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):87-98. PubMed ID: 6306746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of inferior olive-climbing fibers to p,p'-DDT-induced myoclonus in rats.
    Hwang EC; Plaitakis A; Magnussen I; Van Woert MH
    Neurosci Lett; 1981 Jun; 24(1):103-8. PubMed ID: 7266934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p,p'-DDT-induced myoclonus in the rat and its application as an animal model of 5-HT-sensitive action myoclonus.
    Pratt JA; Rothwell J; Jenner P; Marsden CD
    Adv Neurol; 1986; 43():577-88. PubMed ID: 2418651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimyoclonic action of clonazepam: the role of serotonin.
    Chung Hwang E; Van Woert MH
    Eur J Pharmacol; 1979 Nov; 60(1):31-40. PubMed ID: 520416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDT-induced myoclonus: serotonin and alpha noradrenergic interaction.
    Hwang EC; Van Woert MH
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):257-66. PubMed ID: 37558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline.
    Biggio G; Costa E; Guidotti A
    J Pharmacol Exp Ther; 1977 Jan; 200(1):207-15. PubMed ID: 13199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between cerebellar cyclic GMP and motor effects induced by deltamethrin: independence of olivo-cerebellar tract.
    Brodie ME
    Neurotoxicology; 1983; 4(4):1-11. PubMed ID: 6322058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Milacemide increases 5-hydroxytryptamine and dopamine levels in rat brain--possible mechanisms of milacemide antimyoclonic property in the p,p'-DDT-induced myoclonus.
    Truong DD; Galloway MP; Pezzoli G; Jamrozik Z; Fahn S
    Pharmacol Biochem Behav; 1989 Apr; 32(4):993-1001. PubMed ID: 2572009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antimyoclonic action of clonazepam through a GABA--independent mechanism.
    Paul V; Krishnamoorthy MS
    Indian J Physiol Pharmacol; 1989; 33(4):243-6. PubMed ID: 2620967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycine involvement in DDT-induced myoclonus.
    Truong DD; Garcia De Yebenes J; Pezzoli G; Jackson-Lewis V; Fahn S
    Mov Disord; 1988; 3(1):77-87. PubMed ID: 3173367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of climbing and mossy fiber input to mouse cerebellar Purkinje cells by cholecystokinin.
    Wood PL; Steel DJ; Kim HS; Petrack B; Altar CA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):58-62. PubMed ID: 2826774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in brain guanosine 3',5'-monophosphate (cGMP) content by thyrotropin-releasing hormone.
    Mailman RB; Frye GD; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1979 Feb; 208(2):169-75. PubMed ID: 33261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of prostaglandins in the antimyoclonic action of clonazepam.
    Hwang EC; Van Woert MH
    Eur J Pharmacol; 1981 Apr; 71(1):161-4. PubMed ID: 7238584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p,p'-DDT myoclonic/epileptic model: serotonin receptor binding and behavioral studies in the rat.
    Pranzatelli MR; Tailor PT; Pluchino R; Gonzales W; Simmens S
    Neurotoxicology; 1994; 15(2):261-72. PubMed ID: 7991214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p,p'-DDT-induced alterations in brain serotonin metabolism.
    Chung Hwang E; Van Woert MH
    Neurotoxicology; 1981 Dec; 2(4):649-57. PubMed ID: 6176920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity-induced elevation of cerebellar cyclic GMP occurs in the absence of climbing fiber pathways.
    McCaslin PP; Morgan WW
    Brain Res; 1987 Jun; 414(2):381-4. PubMed ID: 3040168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of tolerance to chronic barbital treatment in the cerebellar cyclic guanosine monophosphate system and its response to subsequent barbital abstinence.
    Lane SJ; Morgan WW
    J Pharmacol Exp Ther; 1985 Sep; 234(3):569-74. PubMed ID: 2993585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p,p'-DDT-induced myoclonus in mice: the effect of enhanced 5-HT neurotransmission.
    Magnussen I
    Acta Pharmacol Toxicol (Copenh); 1985 Feb; 56(2):87-90. PubMed ID: 2986413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimyoclonic effect of gabapentin in a posthypoxic animal model of myoclonus.
    Kanthasamy AG; Vu TQ; Yun RJ; Truong DD
    Eur J Pharmacol; 1996 Feb; 297(3):219-24. PubMed ID: 8666053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
    Ryder JW; Falcone JF; Manro JR; Svensson KA; Merchant KM
    J Pharmacol Exp Ther; 2006 Oct; 319(1):293-8. PubMed ID: 16803862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.